← Back to Clinical Trials
RecruitingNCT07134387

Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionBronchopulmonary Dysplasia (BPD)
SponsorGlobal Foundation for the Care of Newborn Infants
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment480
SexALL
Min Age0 Years
Max Age18 Years
Start Date2025-09-16
Completion2026-02
Interventions
N/A, no intervention, participation in survey

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The objective of this study is to examine the long-term impact of having a child with Bronchopulmonary Dysplasia (BPD) on the parents and caregivers from the time of diagnosis through adulthood. The primary focus will be on parents and caregivers of children until the age of 18 (\< 18) years who were diagnosed with BPD as newborns. Data will be collected through an online questionnaire in France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), and the United States. It will ask about inclusion and exclusion criteria, background information (caregiver, child, and family situation), the child's medical situation, parental health-related quality of life (HRQoL), health literacy, feelings, support structures, and economic burden of the family.

Eligibility Criteria

Inclusion Criteria: BPD-group: * Being a parent or primary caregiver of a child until the age of 18 years (0 to under 18 years), * who was born preterm (before 37 weeks of gestation), * who has been discharged from their initial hospital stay after birth, * who suffered from BPD in the newborn period and * who was born or is currently living in the following countries: France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland) and the United States * providing sufficient proficiency in one of the languages of the questionnaire Control group: * Being a parent or primary caregiver of a child until the age of 18 years (0 to under 18 years), * who was born preterm (before 37 weeks of gestation), * who has been discharged from their initial hospital stay after birth, * who did not suffer from BPD in the newborn period and * who was born or is currently living in the following countries: France, Germany, Italy, the Netherlands, Spain, the United Kingdom (

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology